As eSource ecosystems expanded, navigating complexity became the challenge.

Clinical ink was expanding rapidly across that transformation. Its platform had evolved over 17+ years, supported multiple FDA-approved programs, and helped pioneer integrated eSource infrastructure for modern trials. But as the ecosystem expanded, the challenge shifted from technology to navigation.

26FIVE developed an interactive platform built around clinical decision-making. Researchers could explore the ecosystem across phases and methodologies through one navigable experience. The award-winning platform strengthened Clinical Ink’s position in modern clinical data collection.